120
Participants
Start Date
December 31, 2025
Primary Completion Date
December 31, 2030
Study Completion Date
May 31, 2031
Prasinezumab
Prasinezumab 1500 mg monthly infusion
Sodium Chloride
Saline infusion (0,9 % sodium chloride) monthly infusion
Sorbonne University, Pitié-Salpêtrière Hospital, Paris
University Hospital Tubingen, Tübingen
University of Brescia and ASST Spedali Civili of Brescia, Brescia
Fondazione IRCCS Ca' Granda Policlinico Hospital, Milan
University of Luxemburg, Luxembourg
Hospital Universitario HM Puerta del Sur, Madrid, Madrid
Karolinska University of Stockholm, Stockholm
University of Oxford, Oxford
University Hospital Tuebingen
OTHER